PubMed:23516031 JSONTXT

{"project":"Allie","denotations":[{"id":"SS1_23516031_2_0","span":{"begin":128,"end":165},"obj":"expanded"},{"id":"SS2_23516031_2_0","span":{"begin":167,"end":170},"obj":"abbr"}],"relations":[{"id":"AE1_23516031_2_0","pred":"abbreviatedTo","subj":"SS1_23516031_2_0","obj":"SS2_23516031_2_0"}],"text":"Periarticular injection in knee arthroplasty improves quadriceps function.\nBACKGROUND: The postoperative analgesic potential of periarticular anesthetic infiltration (PAI) after TKA is unclear as are the complications of continuous femoral nerve block on quadriceps function.\nQUESTIONS/PURPOSES: We asked (1) whether PAI provides equal or improved postoperative pain control in comparison to a femoral nerve block in patients who have undergone TKA; and (2) if so, whether PAI improves early postoperative quadriceps control and facilitates rehabilitation.\nMETHODS: We randomized 60 patients to receive either PAI or femoral nerve block. During the first 5 days after TKA, we compared narcotic consumption, pain control, quadriceps function, walking distance, knee ROM, capacity to perform a straight leg raise, and active knee extension. Medication-related side effects, complications, operating room time, and hospitalization duration were compared.\nRESULTS: Opioid consumption was lower in the PAI group during the first 8 postoperative hours (12.5 mg versus 18.7 mg morphine), as was reported pain at rest (1.7 versus 3.5 on a 10-point VAS). Thereafter, narcotic consumption and reported pain were similar up to 120 hours. More subjects in the femoral nerve block group experienced quadriceps motor block (37% versus 0% in the PAI group). On Days 1 to 3, subjects in the PAI group experienced better capacity to perform the straight leg raise, active knee extension, and had longer walking distances.\nCONCLUSIONS: PAI provided pain control equivalent to that of a femoral nerve block while avoiding a motor block and its negative functional impacts. The data suggest it should be considered an alternative to a femoral nerve block.\nLEVEL OF EVIDENCE: Level I, therapeutic study. See Guidelines for Authors for a complete description of levels of evidence."}

{"project":"PMID_GLOBAL","denotations":[{"id":"T1","span":{"begin":27,"end":31},"obj":"Body_part"},{"id":"T2","span":{"begin":232,"end":245},"obj":"Body_part"},{"id":"T3","span":{"begin":394,"end":407},"obj":"Body_part"},{"id":"T4","span":{"begin":617,"end":630},"obj":"Body_part"},{"id":"T5","span":{"begin":760,"end":764},"obj":"Body_part"},{"id":"T6","span":{"begin":801,"end":804},"obj":"Body_part"},{"id":"T7","span":{"begin":823,"end":827},"obj":"Body_part"},{"id":"T8","span":{"begin":828,"end":837},"obj":"Body_part"},{"id":"T9","span":{"begin":1248,"end":1261},"obj":"Body_part"},{"id":"T10","span":{"begin":1437,"end":1440},"obj":"Body_part"},{"id":"T11","span":{"begin":1455,"end":1459},"obj":"Body_part"},{"id":"T12","span":{"begin":1460,"end":1469},"obj":"Body_part"},{"id":"T13","span":{"begin":1568,"end":1581},"obj":"Body_part"},{"id":"T14","span":{"begin":1715,"end":1728},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"uberon_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/UBERON_0001465"},{"id":"A2","pred":"uberon_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/UBERON_0001267"},{"id":"A3","pred":"uberon_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/UBERON_0001267"},{"id":"A4","pred":"uberon_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/UBERON_0001267"},{"id":"A5","pred":"uberon_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/UBERON_0001465"},{"id":"A6","pred":"uberon_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/UBERON_0000978"},{"id":"A7","pred":"uberon_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/UBERON_0001465"},{"id":"A8","pred":"uberon_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/UBERON_2000106"},{"id":"A9","pred":"uberon_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/UBERON_0001267"},{"id":"A10","pred":"uberon_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/UBERON_0000978"},{"id":"A11","pred":"uberon_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/UBERON_0001465"},{"id":"A12","pred":"uberon_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/UBERON_2000106"},{"id":"A13","pred":"uberon_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/UBERON_0001267"},{"id":"A14","pred":"uberon_id","subj":"T14","obj":"http://purl.obolibrary.org/obo/UBERON_0001267"}],"text":"Periarticular injection in knee arthroplasty improves quadriceps function.\nBACKGROUND: The postoperative analgesic potential of periarticular anesthetic infiltration (PAI) after TKA is unclear as are the complications of continuous femoral nerve block on quadriceps function.\nQUESTIONS/PURPOSES: We asked (1) whether PAI provides equal or improved postoperative pain control in comparison to a femoral nerve block in patients who have undergone TKA; and (2) if so, whether PAI improves early postoperative quadriceps control and facilitates rehabilitation.\nMETHODS: We randomized 60 patients to receive either PAI or femoral nerve block. During the first 5 days after TKA, we compared narcotic consumption, pain control, quadriceps function, walking distance, knee ROM, capacity to perform a straight leg raise, and active knee extension. Medication-related side effects, complications, operating room time, and hospitalization duration were compared.\nRESULTS: Opioid consumption was lower in the PAI group during the first 8 postoperative hours (12.5 mg versus 18.7 mg morphine), as was reported pain at rest (1.7 versus 3.5 on a 10-point VAS). Thereafter, narcotic consumption and reported pain were similar up to 120 hours. More subjects in the femoral nerve block group experienced quadriceps motor block (37% versus 0% in the PAI group). On Days 1 to 3, subjects in the PAI group experienced better capacity to perform the straight leg raise, active knee extension, and had longer walking distances.\nCONCLUSIONS: PAI provided pain control equivalent to that of a femoral nerve block while avoiding a motor block and its negative functional impacts. The data suggest it should be considered an alternative to a femoral nerve block.\nLEVEL OF EVIDENCE: Level I, therapeutic study. See Guidelines for Authors for a complete description of levels of evidence."}